Mesalazine-Induced Multi-Organ Hypersensitivity.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 413, doi. 10.1007/BF03256911
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2010 AND VI 30 AND IP 6
Results: 7
1
2
Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 405, doi. 10.1007/BF03256910
- By:
- Publication type:
- Article
3
An Adaptive Design for Phase II Non-Oncology Dose Selection Clinical Trials.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 397, doi. 10.1007/BF03256909
- By:
- Publication type:
- Article
4
Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/ Drospirenone (Yasmin) in Healthy Chinese Women: A Randomized, Open-Label, Controlled, Multicentre Trial.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 387, doi. 10.1007/BF03256908
- By:
- Publication type:
- Article
5
Ketoprofen versus Paracetamol (Acetaminophen) or Ibuprofen in the Management of Fever: Results of Two Randomized, Double-Blind, Double-Dummy, Parallel-Group, Repeated-Dose, Multicentre, Phase III Studies in Children.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 375, doi. 10.1007/BF03256907
- By:
- Publication type:
- Article
6
Dose Proportionality of Fentanyl Buccal Tablet in Doses Ranging from 600 to 1300 μg in Healthy Adult Subjects: A Randomized, Open-Label, Four-Period, Crossover, Single-Centre Study.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 365, doi. 10.1007/BF03256906
- By:
- Publication type:
- Article
7
Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 6, p. 351, doi. 10.2165/11533390-000000000-00000
- By:
- Publication type:
- Article